\
&
Contact us
\
&
Contact us
This was 3 years ago
LocationOnline
ProgrammesThe European Patent Office and the European IP Helpdesk offer an Intellectual Property (IP) lecture series that addresses the IP-related aspects of EU-funded projects in five technical fields: medical technologies, artificial intelligence, green technologies, digital communication and biotechnology. The lectures introduce the main aspects of IP management: notably IP ownership, protection and exploitation. The series includes the following sessions from June onwards:
Also part of the series:
More information on each of the upcoming sessions is available here.
Note: By registering for one of the sessions of the IP lecture series you will also be able to participate in further sessions of the series if you wish to do so.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
